The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients (Q43713490)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2007
edit
Language Label Description Also known as
English
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients
scientific article published in January 2007

    Statements

    The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients (English)
    Esteban Martinez
    Sonia López
    Elisa de Lazzari
    Oscar Miró
    Sergi Vidal
    José L Blanco
    Montserrat Laguno
    Joan A Arnaiz
    Agathe Leon
    Maria Larrousse
    Montserrat Lonca
    Josep Mallolas
    José M Gatell
    1 January 2007
    407-415

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit